- WHO recommends that CBD not be a controlled substance
- Operations at various points in the cannabis and industrial hemp industries
- Launch of new products for convenience stores
Two major trends are fostering the success Marijuana Company of America, Inc. (OTC: MCOA) is having. With 29 states and the District of Columbia now permitting the use of cannabis for either medicinal or recreational purposes and public stigma surrounding cannabinoids fast fading, the cannabis and cannabidiol (CBD) industry is moving toward a maturity that will make it an economic sector to be reckoned with. At the same time, an increasingly health-conscious American public is discovering the benefits of hemp-derived CBD, which, unlike delta-9-tetrahydrocannabinol (THC), is devoid of psychotropic properties.
The company, established in 2015 in California by Don Steinberg and Charles Larsen, is set to execute its vision of creating a diverse portfolio of cannabis- and hemp-based businesses. MCOA has already established a commanding presence at various points in the cannabis and industrial hemp markets, as well as the related services supply chains.
Meanwhile, MCOA’s wholly owned subsidiary, hempSMART™, Inc., continues its mission of bringing high quality hemp-derived CBD-based products to market through its affiliate marketing program. Its patent-pending product, hempSMART Brain, is designed to provide safe and effective support of healthy brain function, and its recently launched hempSMART Full Spectrum Drops offer a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. Moreover, in December 2017, MCOA announced the debut of a new personal care product: hempSMART Pain Cream (http://cnw.fm/MNf1P), and hempSMART Pain Capsules are formulated with 10mg of full spectrum, non-psychoactive CBD per serving, derived from industrial hemp as the core ingredient, which, along with a proprietary blend of other natural ingredients, delivers an all-natural formulation.
MCOA has also partnered with the founders of HoneyB Healthy Living to develop Convenient Hemp Mart, LLC’s BeniHemp branded products targeting convenience stores, according to a recent news release (http://cnw.fm/ZvY2C). MCOA has invested $100,000 into the start-up project in exchange for a 25 percent equity stake.
Now that the Expert Committee on Drug Dependence (ECDD) of the World Health Organization (WHO) has officially recommended that ‘cannabis compound cannabidiol (CBD) not be internationally scheduled as a controlled substance’ (http://cnw.fm/Dm1Um), MCOA looks set for success in the fast developing cannabis and industrial hemp CBD markets.
For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com
More from PsychedelicNewsWire
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) PsychedelicNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. PNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled visibility, recognition and brand awareness. PNW is where news, content and information converge.
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/disclaimer/
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
